Morgan Stanley's decision to maintain an Overweight rating on Vistra indicates a positive outlook for the stock. However, the lowering of the price target from $32 to $31 suggests a slightly reduced growth potential. This mixed signal results in a neutral short-term impact on VST's stock price.